Molly graduated summa cum laude with a BS in Biology and minors in Chemistry and Spanish from University of Arizona in Tucson, AZ in 2010. She began her career in medical research at Translational Genomics Research Institute in Phoenix, AZ. Next, she studied at Yale University in New Haven, CT as a National Science Foundation Graduate Research Fellow, earning her PhD in 2018. Her research focused on cancer epigenetics and mechanisms of resistance to targeted anti-cancer therapies. She is happy to continue to work at her goal of improving the lives of cancer patients as a part of Rubedo’s Oncology team.